ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $589,000 | -43.5% | 20,280 | -45.2% | 0.16% | -49.4% |
| Q3 2020 | $1,043,000 | -18.5% | 36,979 | -6.6% | 0.32% | -24.2% |
| Q2 2020 | $1,280,000 | -22.6% | 39,579 | -2.5% | 0.42% | -37.6% |
| Q1 2020 | $1,653,000 | -35.2% | 40,579 | -1.8% | 0.68% | -12.6% |
| Q4 2019 | $2,549,000 | -11.8% | 41,329 | +4.2% | 0.78% | -17.7% |
| Q3 2019 | $2,890,000 | -9.9% | 39,659 | +1.7% | 0.95% | -9.2% |
| Q2 2019 | $3,207,000 | +5.6% | 39,009 | -9.4% | 1.04% | +3.2% |
| Q1 2019 | $3,036,000 | +42.5% | 43,039 | -9.1% | 1.01% | +26.7% |
| Q4 2018 | $2,131,000 | -18.8% | 47,339 | +1.9% | 0.80% | -3.0% |
| Q3 2018 | $2,626,000 | -1.1% | 46,439 | +16.8% | 0.82% | -7.2% |
| Q2 2018 | $2,656,000 | +26.8% | 39,764 | +10.6% | 0.89% | +25.3% |
| Q1 2018 | $2,094,000 | -1.6% | 35,965 | +9.0% | 0.71% | +1.4% |
| Q4 2017 | $2,127,000 | +47.6% | 33,000 | +20.2% | 0.70% | +43.9% |
| Q3 2017 | $1,441,000 | – | 27,450 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |